![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 7, 5468-5474, February 18, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


¶
**



¶¶
||||
From the
INSERM, U417, Hôpital Robert Debré, 48 Boulevard Serurier, F-75935 Paris Cedex 19, France, ||Stowers Institute for Medical Research, Kansas City, Missouri 64110, **Department of Microbiology/Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107-5541, 
University La Sapienza II, Roma 00161, Italy, and 
Institut des Hautes Etudes Scientifiques, 35 route de Chartres, F-91440 Bures-sur-Yvette, France
The ankyrin repeat-containing protein with a suppressor of cytokine signaling box-2 (ASB2) gene was identified as a retinoic acid-response gene and a target of the promyelocytic leukemia-retinoic acid receptor-
oncogenic protein characteristic of acute promyelocytic leukemia. Expression of ASB2 in myeloid leukemia cells inhibits growth and promotes commitment, recapitulating an early step known to be critical for differentiation. Here we show that ASB2, by interacting with the Elongin BC complex, can assemble with Cullin5·Rbx1 to form an E3 ubiquitin ligase complex that stimulates polyubiquitination by the E2 ubiquitin-conjugating enzyme Ubc5. This is a first indication that a member of the ASB protein family, ASB2, is a subunit of an ECS (Elongin C-Cullin-SOCS box)-type E3 ubiquitin ligase complex. Altogether, our results strongly suggest that ASB2 targets specific proteins to destruction by the proteasome in leukemia cells that have been induced to differentiate.
Received for publication, November 18, 2004
* This work was supported by INSERM, by the CNRS, and by grants from the Fondation de France (to P. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Département de Biologie Cellulaire, Institut Cochin, INSERM, U567, CNRS, UMR8104, Univ. Paris V, F-75014 Paris, France.
¶ Supported by the Ligue Nationale contre le Cancer, by the Société Française d'Hématologie, and by the European Molecular Biology Organization (a European Molecular Biology Organization short term fellowship).
¶¶ Supported by the Société Française d'Hématologie, by the Deutsche Forschungsgemeinschaft, and by the Fondation de France.
|||| Present address and to whom correspondence should be addressed: Département de Biologie Cellulaire, Institut Cochin, INSERM, U567, CNRS, UMR8104, Univ. Paris V, 22 Rue Méchain, F-75014 Paris, France. Tel.: 33-1-40516427; Fax: 33-1-40516430; E-mail: lutz{at}cochin.inserm.fr.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. W. Choi, Y.-M. Seo, E.-A Kim, K. S. Sung, J. W. Ahn, S.-J. Park, S.-R. Lee, and C. Y. Choi Ubiquitination and Degradation of Homeodomain-interacting Protein Kinase 2 by WD40 Repeat/SOCS Box Protein WSB-1 J. Biol. Chem., February 22, 2008; 283(8): 4682 - 4689. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ferguson III, Y. Wu, K. Smith, P. Charles, K. Powers, H. Wang, and C. Patterson ASB4 Is a Hydroxylation Substrate of FIH and Promotes Vascular Differentiation via an Oxygen-Dependent Mechanism Mol. Cell. Biol., September 15, 2007; 27(18): 6407 - 6419. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. McCarthy, J. L. Andrews, E. L. McDearmon, K. S. Campbell, B. K. Barber, B. H. Miller, J. R. Walker, J. B. Hogenesch, J. S. Takahashi, and K. A. Esser Identification of the circadian transcriptome in adult mouse skeletal muscle Physiol Genomics, September 11, 2007; 31(1): 86 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshioka, A. Boivin, C. Bolduc, and J. St-Amand Gender difference of androgen actions on skeletal muscle transcriptome J. Mol. Endocrinol., August 1, 2007; 39(2): 119 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Debrincat, J.-G. Zhang, T. A. Willson, J. Silke, L. M. Connolly, R. J. Simpson, W. S. Alexander, N. A. Nicola, B. T. Kile, and D. J. Hilton Ankyrin Repeat and Suppressors of Cytokine Signaling Box Protein Asb-9 Targets Creatine Kinase B for Degradation J. Biol. Chem., February 16, 2007; 282(7): 4728 - 4737. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Diks, R. J. Bink, S. van de Water, J. Joore, C. van Rooijen, F. J. Verbeek, J. den Hertog, M. P. Peppelenbosch, and D. Zivkovic The novel gene asb11: a regulator of the size of the neural progenitor compartment J. Cell Biol., August 14, 2006; 174(4): 581 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. McDaneld, K. Hannon, and D. E. Moody Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1672 - R1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Reecy, D. M. Spurlock, and C. H. Stahl Gene expression profiling: Insights into skeletal muscle growth and development J Anim Sci, April 1, 2006; 84(13_suppl): E150 - E. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Richardson and W. Zundel The Emerging Role of the COP9 Signalosome in Cancer Mol. Cancer Res., December 1, 2005; 3(12): 645 - 653. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |